Photodynamic therapy and central serous chorioretinopathy.

Abstract

Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal vascular remodeling, leading to a reduction in choroidal congestion, vascular hyperpermeability and extravascular leakage. Furthermore, photodynamic therapy seems to be an effective means of improving or stabilizing visual acuity in patients with central serous chorioretinopathy.

• Authors: Lina Siaudvytyte, Vaida Diliene, Goda Miniauskiene, Vilma Jurate Balciuniene
• Journal: Medical hypothesis, discovery & innovation ophthalmology journal (Med Hypothesis Discov Innov Ophthalmol) Vol. 1 Issue 4 Pg. 67-71 ( 2012) ISSN: 2322-4436 [Print] United States
• PMID: 24600627 (Publication Type: Journal Article)